Editorial standards & corrections

Ownership and authorship

ColdAI LLC owns and publishes Frida. We also own the Frida app, so we have a commercial interest in its use. Educational material must not present that interest as independent evidence that the product improves clinical outcomes.

“Frida Editorial Team” is an organizational byline. It does not identify a clinician or imply medical credentials. Individual author and reviewer names, qualifications and affiliations must be verified before publication. We will not invent credentials, advisory relationships or personal experience.

AI assistance, where used, does not count as clinical review. Generated text, summaries and citations require checking. We are still documenting the creation and review history of the existing library; an article’s byline alone should not be read as a claim about whether AI contributed to it.

What a clinical review label means

A clinical review label may appear only when a verified, named professional with relevant qualifications has approved the exact published version. The record must identify the reviewer, review date and scope. An article’s publication date is not a review date.

Clinical claims, medication information and crisis guidance need appropriate human review. Automated checks can help find problems, but they cannot approve clinical accuracy. Substantive changes require renewed review; an earlier approval does not automatically cover a rewritten article.

Where no qualifying review is recorded, the article must say so. Our articles provide general education and do not diagnose a person, prescribe treatment or replace a care team.

Sources must support the actual claim

Our standard is to use current clinical guidelines, regulatory information, systematic reviews and relevant primary research. A citation must lead to the intended source, with its title, authors, date and identifier checked. A working link to a research website is not sufficient.

• Match evidence to the statement. Check the population, intervention, comparison, outcome and limitations. A source about one drug formulation or one group of people cannot automatically support another.
• Explain uncertainty. Separate association from causation, preliminary research from established care, and performance in a research dataset from validation in clinical practice.
• Keep product evidence separate. Research about an AI model, wearable or therapy does not establish that Frida diagnoses, predicts, prevents or treats schizophrenia.
• Identify the jurisdiction. FDA labels describe US regulatory information. Approval, availability and prescribing requirements can differ elsewhere. US information must not be presented as a global rule.
• Verify practical details. Local services, crisis contacts and eligibility need checks against current official sources and a recorded check date.

Examples of sources readers can consult directly include NIMH’s schizophrenia information, NICE’s guideline on psychosis and schizophrenia in adults, and the WHO guidance on ethics and governance of AI for health. Their inclusion here does not imply endorsement of Frida.

Stories and lived experience

Some Frida articles use illustrative composite stories. These do not depict a verified individual and must not be presented as patient testimonials, interviews or evidence of treatment success. The composite label should be visible on the article and wherever its story is introduced.

Genuine personal contributions require documented consent and provenance, with a clear explanation of pseudonyms or changed details. A person’s account deserves respect, but it does not establish what will happen to another person. Medical statements and advice attached to a story still require evidence and review.

Useful pages, maintained carefully

New articles and changes to article titles, summaries, body text or FAQs require a recorded clinical review before the publishing system accepts them. Existing material remains available during the audit, except for the pages placed on hold. Keeping an existing page available is not clinical approval.

A new article needs a distinct reader purpose and useful, verified substance. We do not treat keyword variations, city names or translation opportunities as sufficient reasons to create pages in bulk.

Closely overlapping articles should be assessed for consolidation. Local guides need verified local information; translations need competent language and clinical review for their intended audience. Publication must stay within our ability to check and maintain the content.

Changes to sources, drug labels, service details or clinical guidance should trigger reassessment of affected articles. Material corrections belong in a visible record. Dates must reflect real publication, updates or completed review—not a cosmetic refresh.

Corrections and temporary holds

The following record covers issues addressed on 25 September 2026. A correction is not a certification that every statement in an article has completed clinical review. Pages on hold remain unavailable as medical guidance while their review is pending.

1. Temporary holds · Emergency advice and central evidence under review

   Emergency guidance and four clinical explanations

   We have temporarily held the cardiovascular guide after finding emergency aspirin advice that conflicts with stroke guidance. Four other guides are held because important references do not match the studies described. Their clinical explanations require source verification and qualified review.

   • Cardiovascular disease: Emergency advice included aspirin for symptoms that can indicate stroke. That advice requires correction and clinical review. Read the stroke guidance.
   • Internalized stigma: References used for self-stigma measurement, outcomes and a named therapy lead to unrelated research. The evidence summary and treatment guidance require source and clinical review. Inspect a cited destination.
   • Anhedonia: An important reference on pleasure processing leads to research on muscle-force coordination. The symptom explanation and treatment guidance require source and clinical review. Inspect the cited destination.
   • Clinical high risk for psychosis: A reference used for psychosis-transition estimates leads to intestinal-cell research. The risk estimates and clinical guidance require source and clinical review. Inspect the cited destination.
   • PANSS symptom scores: A reference used to interpret symptom-severity scores leads to a report on cognitive-task measurement. The score interpretations and clinical-response guidance require source and clinical review. Inspect the cited destination.

   These findings concern specific guidance and attributions. They do not establish that every statement in the affected pages is false. Restoration requires checking the complete corrected guidance, including summaries and frequently asked questions.

2. Temporary holds · Further source and clinical review

   Sixteen additional articles with misattributed central references

   Further checks found references that do not match the studies described in these articles. Because those references were cited in support of central clinical or intervention claims, we have temporarily held the pages while their sources and guidance are reviewed.

   • Animal-assisted therapy: A reference used for animal-assisted therapy outcomes leads to research on adolescent trauma and dissociation. The intervention-efficacy and practical guidance require source and clinical review. Inspect the cited destination.
   • Choline and schizophrenia: A reference described as a prenatal choline trial leads to research on religious beliefs and depression. Pregnancy, prevention and supplementation claims require source and clinical review. Inspect the cited destination.
   • Circadian rhythms and schizophrenia: A central sleep-rhythm reference leads to a skeletal-disease report. The evidence summary and practical light, melatonin and medication guidance require source and clinical review. Inspect the cited destination.
   • Compassion-focused therapy: A reference described as a compassion-focused therapy meta-analysis evaluates routine CBT outcomes for voices. The intervention-efficacy and practice claims require source and clinical review. Inspect the cited destination.
   • Coordinated specialty care: The reference offered for the RAISE clinical trial leads to a rosemary experiment in worms. The specific trial and care-outcome claims require source and clinical review. Inspect the cited destination.
   • Exercise and antipsychotic weight gain: A reference used for exercise-related weight outcomes leads to liver-cancer biomarker research. Comparative treatment and weight-outcome claims require source and clinical review. Inspect the cited destination.
   • Invega Trinza: A reference described as a paliperidone maintenance trial leads to a sun-protection study. Formulation-specific efficacy and trial-comparison claims require source and clinical review. Inspect the cited destination.
   • Injectable and oral antipsychotics: A reference used for comparative medication outcomes leads to a correction concerning older-person care. Relapse and hospitalization comparisons require source and clinical review. Inspect the cited destination.
   • Loving-kindness meditation: A reference described as a schizophrenia meditation trial leads to an attachment survey of college students. The efficacy, population and practice claims require source and clinical review. Inspect the cited destination.
   • Magnesium and schizophrenia: A central magnesium reference leads to a review of zinc in female reproductive disorders. Schizophrenia-specific evidence and supplementation guidance require source and clinical review. Inspect the cited destination.
   • Mindfulness and schizophrenia: A reference offered as a mindfulness evidence review leads to research on thalamic volume and novelty seeking. The efficacy and adapted-practice guidance require source and clinical review. Inspect the cited destination.
   • Nightmares and antipsychotics: A reference described as a medication-induced nightmare review leads to an intestinal-obstruction case report. Medication and nightmare-management claims require source and clinical review. Inspect the cited destination.
   • The RAISE trial: The article’s defining trial reference leads to a rosemary experiment in worms. The trial design, outcomes and interpretation require source and clinical review. Inspect the cited destination.
   • The Soteria care model: The reference offered as a Soteria comparative-care review is a different article about remission and recovery. Claims about medication-minimal care require source and clinical review. Inspect the cited destination.
   • Yoga postures and schizophrenia: A reference offered as yoga evidence leads to genetic-association and visual-masking research. The symptom-efficacy and practical exercise guidance require source and clinical review. Inspect the cited destination.
   • Zinc and schizophrenia: A reference used for schizophrenia biomarker and supplement claims leads to research measuring healthy gums. Supplementation and medication-interaction guidance require source and clinical review. Inspect the cited destination.

   These are targeted editorial holds. They do not establish that every statement is false or that the treatments or support approaches themselves are ineffective or unsafe. A matching reference elsewhere on a page does not resolve the incorrect attribution. Restoration requires checking the intended evidence, what it supports, and the wider clinical guidance.

3. Temporary holds · Clinical guidance and research references under review

   Three additional clinical guides with mismatched research references

   Further source checks found unrelated destinations in the following articles. We have temporarily held them while their references and clinically significant claims are reviewed.

   • Severe constipation on antipsychotics: a reference described as a review of clozapine-related gastrointestinal harm leads to a veterinary association annual report. The medication-harm statistics and constipation-treatment guidance require review.
   • Molindone: a reference offered for a comparison of antipsychotics in children and adolescents leads to a study of electric fields and tumor spread. The comparative medication and weight-gain claims require review.
   • Catatonia: references described as catatonia prevalence and immune-system research lead to a review of low vision and visual rehabilitation and a cuttlefish reproduction study. The emergency-care and treatment guidance require review.

   These mismatches establish incorrect references; they do not by themselves show that every associated claim is false. Restoring an article requires checking the intended sources, what they support, and the wider clinical guidance. The holds preserve the original material for review.

4. Temporary holds · Research references and associated claims under review

   Fifteen additional articles with mismatched research references

   Our source audit found references that point to different papers from those described. For example, a link described as an antipsychotic analysis instead leads to a news article about US abortion policy. We have temporarily held the following articles because the references are used to support treatment, symptom, outcome or decision guidance.

   • Medication articles: Aristada, haloperidol decanoate, Uzedy, and alcohol and clozapine.
   • Exercise articles: exercise, running, and team sports.
   • Symptom articles: anhedonia, flat affect, and auditory hallucinations.
   • Care and decision guides: racial disparities in diagnosis, duration of untreated psychosis, early intervention services, disclosure decisions, and self-stigma.

   A mismatched reference does not, by itself, establish that the associated claim is false. Review must verify both the intended source and what it actually supports. These holds preserve the articles for correction; they do not imply that the rest of the library has completed source or clinical review.

5. Reference corrected · 25 September 2026

   Schizophrenia AI research guide

   The digital-phenotyping reference linked to an unrelated paper. Both the reference and the surrounding description have been corrected to identify the 2016 perspective by Onnela and Rauch. This source is a perspective, not a trial proving clinical benefit.

   Read the AI research guide

6. Corrections prepared · Article held for clinical review

   Erzofri medication article

   Incorrect dosing information has been removed, and misleading initiation language and research citations have been corrected in the article under review. The article remains on hold pending qualified clinical review. The original wording should not be used for medication decisions.

   The review uses the US Erzofri prescribing information. The corrected PRIDE study reference concerns a different paliperidone formulation and must not be presented as direct evidence for Erzofri.

   View the Erzofri article status

7. Temporary hold · Clinical and source review pending

   Two command-hallucination articles

   We have held these articles because coping suggestions could be misinterpreted in a situation involving harmful commands. The review also covers citation errors and overlapping content. A temporary hold does not mean that people who hear voices are inherently dangerous.

   Command auditory hallucinations: what they are, how to cope
   Command hallucinations: voices that tell you what to do

8. Temporary hold · Clinical review pending

   Ketamine and psychosis article

   The article’s contraindication framing did not adequately distinguish a formal contraindication from a warning requiring clinical assessment. It is on hold while those distinctions and the wider treatment discussion are reviewed against appropriate sources, including the US Spravato label.

   View the ketamine article status